NAS:MDCO (USA) Also Trade In: Germany
The Medicines Co $ 84.9 0 (0%)
Warning! GuruFocus has detected with MDCO. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for The Medicines Co () from 2000 to Oct 29 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. The Medicines stock (MDCO) PE ratio as of Oct 29 2020 is 0. More Details
The Medicines PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
The Medicines PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare SZSE:300142 HAM:SAZ TSE:4506 BOM:500124 LSE:HIK XPAR:IPN TSX:WEED OCSE:LUN OSTO:SOBI HKSE:03320 NSE:DIVISLAB TSE:4516 SHSE:600332 SZSE:002001 NYSE:PRGO SHSE:600085 SHSE:603707 BSP:HYPE3 SZSE:000963 NSE:AUROPHARMA
Address 8 Sylvan Way, Parsippany, NJ, USA, 07054
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.